In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown ...
A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies. A study from researchers at the ...
Hosted on MSN
Single-cell RNA sequencing of bone metastases from multiple cancer types reveals three distinct immune archetypes
Bone is a common site for metastasis of solid cancers, but histological and molecular features of bone metastases are not well understood. In a new study published in Cell Genomics, researchers at ...
Bone cancer in the leg, while relatively uncommon, presents with specific warning signs that warrant immediate medical attention. Understanding these symptoms enables individuals to seek prompt ...
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...
GRAND RAPIDS, Mich. (WOOD) — July is Bone Cancer Awareness Month. Though it is rare, it can be difficult for those affected by it. Dr. Matthew Steensma, the chief for orthopedic oncology at Corewell ...
Researchers have developed a magnetic nanomaterial that can kill bone cancer cells and support bone regeneration at the same time. The material heats up under a magnetic field to destroy tumors, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results